Phototherapeutic light for treatment of pathogens

US12397169B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12397169-B2
Application numberUS-202117148124-A
CountryUS
Kind codeB2
Filing dateJan 13, 2021
Priority dateJul 28, 2015
Publication dateAug 26, 2025
Grant dateAug 26, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and related devices for impinging light on tissue, for example within a body of a patient, to induce various biological effects are disclosed. Biological effects may include at least one of inactivating and/or inhibiting growth of one or more pathogens, upregulating a local immune response, stimulating enzymatic generation of nitric oxide to increase endogenous stores of nitric oxide, releasing nitric oxide from endogenous stores of nitric oxide, and inducing an anti-inflammatory effect. Wavelengths of light are selected based on intended biological effects for one or more of targeted tissue types and targeted pathogens. Light treatments may provide multiple pathogenic biological effects, either with light of a single wavelength or with light having multiple wavelengths. Devices and methods for light treatments are disclosed that provide light doses for inducing biological effects on various targeted pathogens and targeted tissues with increased efficacy and reduced cytotoxicity.

First claim

Opening claim text (preview).

What is claimed is: 1. An illumination device comprising: at least one light source arranged to impinge light on mammalian tissue within a body, the light comprising a first light characteristic and configured to induce a biological effect; driver circuitry configured to drive the at least one light source; an illumination head that forms a distal end of the illumination device, the illumination head coupled to a single rotation yoke configured for adjusting the illumination head at both a tilt angle and a rotation angle within the body to provide angled delivery of the light to the mammalian tissue; an inflation bladder between the single rotation yoke and the at least one light source; and an adjustment control element configured to adjust the tilt angle, the adjustment control element configured to be positioned outside the body during use; wherein the biological effect comprises altering a concentration of one or more pathogens within the body and altering growth of the one or more pathogens within the body. 2. The illumination device of claim 1 , further comprising an optic that is arranged to pass the light from the at least one light source for irradiating the mammalian tissue within the body. 3. The illumination device of claim 2 , wherein the optic is further arranged in optical communication with a camera for viewing the mammalian tissue within the body. 4. The illumination device of claim 2 , wherein the optic resides on the illumination head. 5. The illumination device of claim 2 , further comprising a light guide that is arranged between the optic and the at least one light source. 6. The illumination device of claim 2 , further comprising a protective covering that comprises a same material as the optic. 7. The illumination device of claim 1 , further comprising a light source housing, wherein the at least one light source is within the light source housing, and wherein the illumination head is removably attached to the light source housing. 8. The illumination device of claim 1 , wherein the illumination device is configured to be user controlled. 9. The illumination device of claim 1 , wherein the illumination device is configured to be at least partially inserted within a body cavity, and wherein the mammalian tissue is included within the body cavity. 10. The illumination device of claim 9 , wherein the at least one light source is arranged outside of the body cavity when the illumination device is partially inserted within the body cavity. 11. The illumination device of claim 9 , wherein the at least one light source is arranged within the body cavity when the illumination device is partially inserted within the body cavity. 12. The illumination device of claim 1 , wherein the illumination device is configured to be fully inserted within a body cavity, and wherein the mammalian tissue is included within the body cavity. 13. The illumination device of claim 12 , further comprising a cable that is configured to retrieve the illumination device from the body cavity. 14. The illumination device of claim 1 , further comprising a microcontroller that is configured to control the driver circuitry. 15. The illumination device of claim 14 , wherein the microcontroller is further configured to receive an input from at least one sensor for controlling the at least one light source. 16. The illumination device of claim 15 , wherein the at least one sensor comprises one or more of a temperature sensor and a proximity sensor. 17. The illumination device of claim 1 , wherein the biological effect further comprises upregulating a local immune response within the body. 18. The illumination device of claim 1 , wherein the biological effect comprises stimulating at least one of enzymatic generation of nitric oxide to increase endogenous stores of nitric oxide and releasing nitric oxide from endogenous stores of nitric oxide. 19. The illumination device of claim 1 , wherein the biological effect comprises inactivating the one or more pathogens that comprise a cell-free virus. 20. The illumination device of claim 1 , wherein the biological effect comprises inhibiting replication of the one or more pathogens that are in a cell-associated environment within the body. 21. The illumination device of claim 1 , wherein impinging the light to the mammalian tissue within the body comprises administering a dose of light in a range from 0.5 joules per square centimeter (J/cm 2 ) to 100 J/cm 2 . 22. The illumination device of claim 1 , wherein the first light characteristic comprises at least one of a first peak wavelength and a radiant flux. 23. The illumination device of claim 22 , wherein the first light characteristic is the first peak wavelength and the first peak wavelength is in a range from 400 nanometers (nm) to 900 nm. 24. The illumination device of claim 23 , wherein the light further comprises a second peak wavelength in a range from 400 nm to 900 nm, and the second peak wavelength is different than the first peak wavelength. 25. The illumination device of claim 22 , wherein the first peak wavelength is in a range from 410 nm to 440 nm. 26. The illumination device of claim 1 , further comprising a heat sink arranged to provide a heat dissipation path away from the at least one light source and away from the illumination head.

Assignees

Inventors

Classifications

  • Integrated devices comprising at least one light-emitting semiconductor component covered by group H10H20/00 (active-matrix LED displays H10H29/30) · CPC title

  • Vagina · CPC title

  • Visible light · CPC title

  • Arrays of diodes · CPC title

  • the applicator adapted to be worn on the head · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12397169B2 cover?
Methods and related devices for impinging light on tissue, for example within a body of a patient, to induce various biological effects are disclosed. Biological effects may include at least one of inactivating and/or inhibiting growth of one or more pathogens, upregulating a local immune response, stimulating enzymatic generation of nitric oxide to increase endogenous stores of nitric oxide, r…
Who is the assignee on this patent?
Know Bio Llc
What technology area does this patent fall under?
Primary CPC classification A61N5/0624. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).